[1]
P. Popovič, M. Šljivič, M. Sever, J. Ocvirk, T. Mesti, and E. Brecelj, “Prognostic factors for overall survival and safety of DEBIRI TACE in patients with colorectal liver metastases”, Radiol Oncol, vol. 58, no. 2, pp. 214–220, Jun. 2024.